Wednesday, 30 December 2015
Medical Profession Urged to Adopt New Technology
Chamber member Mimex-Montague Healthcare is urging the medical profession to adopt a radical new way of diagnosing and treating long-term conditions such as diabetes.
It says that applying a neurological approach could save the National Health Service billions of pounds a year.
CEO Graham Ewing said: “Putting it simply, it is widely recognised that colour perception is altered in the diabetic. This happens because proteins give out pulses of light known as biophotons when they react and which influences our perception of colour.
"It is also recognised that flashing lights can both cause and treat migraine and can be used to treat dyslexia.
"Both examples illustrate the scientific principles behind the Strannik Virtual Scanning and Strannik Light Therapy technology, devised by Russian researcher and Mimex-Montague Healthcare’s founder and Technical Director Dr Igor Grakov.
“Dr Grakov’s research has addressed the theoretical void between cognition and molecular biology, identified by Nobel Laureate Professor Eric Kandel, and his research into the medical application of industrial lasers led Dr Grakov to develop the first accepted recognition of the process by which the brain naturally regulates the body's function.
“He successfully mathematically modelled the consequences of sensory input upon the nervous system and the physiological systems of the body, thereby providing a neurological treatment route for various disorders. It is an immensely significant development.”
Nottingham-based Montague Healthcare merged with the Russian company Mimex in January 2014 to form Mimex Montague Healthcare Limited (MMHL), since when Graham and the rest of the team at MMHL has been promoting Strannik technology throughout the world.
“Diabetes alone costs the NHS about £10bn a year but by using Strannik that bill could, in theory, be cut to c£2.8bn,” said Graham.
“But, despite having 50 or 60 published papers on the subject, and having the necessary legal status, ie, to place the technology on the market, Strannik is seen as an annoying inconvenience, perhaps because healthcare is so conservative and change-averse.
"Nevertheless, the technology is CE-marked to diagnose and treat a wide range of medical conditions at significantly lower cost than contemporary options,” he added.Back